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Abstract
Background: Development of a fast and accurate scoring function in virtual screening remains a
hot issue in current computer-aided drug research. Different scoring functions focus on diverse
aspects of ligand binding, and no single scoring can satisfy the peculiarities of each target system.
Therefore, the idea of a consensus score strategy was put forward. Integrating several scoring
functions, consensus score re-assesses the docked conformations using a primary scoring function.
However, it is not really robust and efficient from the perspective of optimization. Furthermore, to
date, the majority of available methods are still based on single objective optimization design.
Results: In this paper, two multi-objective optimization methods, called MOSFOM, were
developed for virtual screening, which simultaneously consider both the energy score and the
contact score. Results suggest that MOSFOM can effectively enhance enrichment and performance
compared with a single score. For three different kinds of binding sites, MOSFOM displays an
excellent ability to differentiate active compounds through energy and shape complementarity.
EFMOGA performed particularly well in the top 2% of database for all three cases, whereas
MOEA_Nrg and MOEA_Cnt performed better than the corresponding individual scoring functions
if the appropriate type of binding site was selected.
Conclusion: T h em u l t i - o b j e c t i v eo p t i m i z a t i o nm e t h o dw a ss u c c e s s f u l l ya p p l i e di nv i r t u a l
screening with two different scoring functions that can yield reasonable binding poses and can
furthermore, be ranked with the potentially compromised conformations of each compound,
abandoning those conformations that can not satisfy overall objective functions.
Background
With the thriving development and confirmative sig-
nificance of computational chemistry in drug discovery,
more and more medicinal chemists and pharmacologists
are using computational methods in their drug discovery
research[1, 2], and numerous drugs developed based on
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Open Accessthe clues provided by computations (modeling and
simulation) have entered clinical trials or have been
launched into the market already[3]. For the computa-
tional chemist, an attractive goal is to develop computer
programs capable of automatically evaluating large-scale
chemical libraries (databases). These computational
methods are referred to as virtual screening (VS)[4]. In
general, two strategies have been employed in virtual
screening: (1), using pharmacophore-based database
searching (PBDS) methods to identify potential hits
from chemical libraries, mostly in the cases where three-
dimensional (3D) structures of the targets are unknown;
and (2), using molecular docking approaches to screen
the libraries in cases where the 3D structures of the
targets are available[4, 5]. Because more and more 3D
structures of drug target proteins are available, VS with
molecular docking approaches has become promising, as
demonstrated by numerous recent examples[2, 6-10].
The core steps of structure-based virtual screening (SBVS)
are docking and scoring. Since Kuntz et al.[11] published
the first docking algorithm DOCK in 1982, numerous
docking programs have been developed during the past
two decades [12-25]. Several comprehensive reviews of
the advances of docking algorithms and applications
have been published [26-30]. Scoring (ranking) the
compounds retrieved from a database is performed
simultaneously with the docking simulation. Molecular
docking is a typical optimization problem, for it is
difficult to obtain the global optimum solution. As the
fitness during the optimization process, scoring function
should be fast and accurate enough, allowing simulta-
neous ranking of the retrieved poses in the optimization
process. Based on this idea, several scoring functions
have been developed [31-33]. Unfortunately, there is no
scoring function developed so far that can reliably and
consistently predict a ligand-protein binding mode and
the binding affinity at the same time[31, 32, 34].
Therefore, heuristic docking and consensus score strate-
gies are often used in virtual screening [34-36].
Since a huge number of compounds in a database have
to be thoroughly tested in the virtual screening process,
several crucial issues have to be addressed. One is the
computational cost; only docking programs capable of
docking a flexible ligand within a reasonable time scale
are acceptable for virtual screening[34]. The other one is
the ability to discriminate between true actives and
inactive compounds; only those docking approaches
able to distinguish the active molecules rapidly and
accurately, are suitable for virtual screening applications
in practice. Although the consensus score strategy has
demonstrated an advantage over single scores, it is
actually based on the results of single scoring optimiza-
tion. This means that consensus scoring only re-scores a
limited molecules or conformations (generally 30 or
more), thereby inevitably losing a number of true
positives[33, 34]. To some extent, consensus scoring
seems to be far-fetched and artificial [37].
Most conformational optimization methods in docking
program can only deal with a single objective, such as
binding energy, shape complementarity, or chemical
complementarity. However, real-world problems nor-
mally involve multiple objectives (possibly conflicting
ones) or optimization criteria, which should be satisfied
simultaneously, and suitable solutions to the overall
problem cannot be found by using individual optimiza-
tion algorithms with single objectives[38]. For example,
an optimization solution for the binding affinity
(energy) between a ligand and a receptor is usually not
the optimization solution for other criteria (e.g. shape or
chemical complementarity, etc.). Similar problems in
combinatorial library design and structural superposi-
tion of three-dimensional molecules have been reported
[39, 40]. Thus, there is a need for an optimization
algorithm compromising several objectives, which may
result in more reasonable and robust binding modes
between ligands and receptors. In fact, it is a problem of
multi-objective optimization (MO)[41], which tends to
find a set of alternative good compromises, generally
known as pareto-optimal solutions. These solutions are
optimal because no other solutions in the search space
superior to them when all objectives are considered.
Then, the 'optimum' is chosen by the design which fits
better in a certain application.[42] There are more than
twenty mathematical multi-objective optimization tech-
niques[43, 44]. However, due to their inherent paralle-
lism, evolutionary algorithms (EAs) and genetic
algorithms (GAs) are still the top priority in terms of
finding multiple pareto-optimal solutions for multi-
objective optimization problems[45].
In this paper, two sets of MO methods, denoted
MOSFOM (Multi-Objective Scoring Function Optimiza-
tion Methodology), were adopted for the binding
conformation search of a small molecule within the
binding site of a protein using two scoring functions as
the objectives. Different from consensus score, MOSFOM
does not re-score or re-rank the candidates from the
primary virtual screening with one or several other
scoring functions, but scores all the molecules in a
chemical database with two or more scoring functions
simultaneously during the binding pose optimization.
Testing results indicate that MOSFOM, which is able to
enhance hit rates and greatly reduces the false-positive
rate, is more robust and reasonable than the consensus
strategy as an alternate tool for large-scale library virtual
screening. Here, MOSFOM emphasizes a new strategy to
obtain the most reasonable binding conformation[46]
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rather than to accurately predict the binding free energy
or the combination of several scoring functions. Conse-
quently, MOSFOM can be used in the prioritization of
ligands in high-throughput virtual screening.
Methods
Preparation of target proteins
Thrombin,theestrogenreceptoralpha,andcyclooxygenase-2
(COX-2) have been used as target proteins for testing the
newly developed docking algorithms in this study. The
coordinates of the X-ray crystal structures of these three
proteins were retrieved from the Protein Data Bank (PDB)
[47], including thrombin in complex with Mqpa at 2.2 Å
resolution (PDB entry 1ETR)[48], estrogen receptor(ER) in
complexwith4-hydroxytamoxifenat1.90Åresolution(PDB
entry 3ERT)[49], and cyclooxygenase-2(COX-2) in complex
with Sc-558 at 3.0 Å resolution (PDB entry 6COX)[50]. All
water molecules were removed from the protein structures.
Afterextractionofboundligands,allhydrogenatomsandthe
Kollmanall-atomchargeswereassignedtotheproteinsusing
the BIOPOLYMER module of Sybyl v6.8 (Tripos Associates,
I n c .S t .L o u i s ,M O ) .F i n a l l y ,f o re a c hp r o t e i nt a r g e t ,t h e
binding site was defined as the residues around the bound
ligand within 6.5 Å. Gasteiger and Marsili charges[51] were
assigned to the extracted ligand of each protein.
Preparation of compounds libraries
For all three targets (thrombin, ER and COX-2), the active
compounds were selected from the MDDR (MDL ISIS/
HOST software, MDL Information Systems, Inc.). Active
compounds with molecular weights between 200 and 600
wereselectedasdrug-likecompounds,andthosecontaining
water molecules and ions were eliminated. Table 1 shows
the number of active compounds for each target. Another
10,000 randomly 'varied' compounds with molecular
weights between 200 and 600 were selected as drug-
concerned decoys from the Available Chemical Directory
(ACD) after eliminating chemical reagents and inorganic
compounds by means of CORINA. All compounds of
different test libraries were stored as SDF format file using
the MDL ISIS_Base program (MDL ISIS/HOST software,
MDL Information Systems, Inc.), and their three-dimen-
sional coordinates were converted using a script written in
the Sybyl programming language (SPL), and Gasteiger-
Marsili atomic charges were assigned to each molecule. The
final coordinates of each molecule were then stored in
multi-mol2 files. Protonation states were correctly given for
all the compounds.
Scoring functions
The energy score and contact score of DOCK [52-54]
were used in this work. Energy score based on the
AMBER force field[55] was composed of steric and
electrostatic terms. ε(r) = 4r was used for the coefficient
of the dielectric for the Coulomb potential, and Lennard-
Jones 6–12 was used for Van der Waals (VDW) potential.
Contact score is a summation of the heavy atom contacts
between the ligand and the receptor, which provides a
simple assessment of shape complementarity; if two
atoms approach close enough to bump into one another,
then the interaction can be penalized by a certain
amount. In this study, a 4.5-Å contact distance cutoff
was used, with 50 penalized for each clash.
Calculation of the enrichment factor
The enrichment factor is a key parameter to evaluate the
quality of the docking and scoring compared to a
random selection[33, 56]. The enrichment factor (EF)
is defined as
EF(subset size)
Hitss
Ns
Hitst
Nt
= / (1)
where Hitss is the number of active compounds in the
sampled subset, Hitst is the total number of active
compounds in the database and N is the number of
compounds. In general, the enrichment factor is against
random screening; it is evident that the maximum
enrichment is determined by the total number of active
compounds and the total number of molecules in the
database. For instance, there are 695 active compounds
among the total 10695(10000+695) molecules in the
database for the COX-2 case, i.e. the achievable
maximum is 10695/695 ≈ 15. If 5% of active com-
pounds were found among the top 1% of the database,
then the enrichment factor would be fivefold over
random (EF = 5) at the 1% of the database.
There are three criteria to evaluate the effectiveness of a
docking program as indicated by Wei et al.[ 5 6 ] :t h e
Table 1: Number of the active compounds for each target used in this study
Target MW Cutoff No. Actives No. Selected Range RB (Mean) Theoretical Maximum
of Enrich Factor
Thrombin 200–600 847 646 4–29 (12.4) 16.47
ER 200–600 134 105 3–17 (8.5) 96.23
COX-2 200–600 698 695 0–17 (4.0) 15.39
Random database 200–600 10000 0–35 (4.5)
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active compounds retrieved, which represent the ability
to find active compound of the docking program and
scoring function.
ε-MOEA Method
A steady-state MOEA based on the ε-dominance concept
[57] is a pragmatic and fast multi-objective evolutionary
algorithm for finding well-spread pareto-optimal solu-
tions. An EA population P(t) and an archival population
E(t) (t is the iteration counter) were used as two co-
evolving populations in ε-MOEA. After initialization,
two solutions from P(t) and E(t) were chosen for mating.
Then, each of these offspring solutions was compared
with the archive and the EA population for possible
inclusion. For the case of j objectives, the search space
and objective space were divided into hyper-boxes (a
number of grids, each having the size εj in the jth
objective) to ensure that a hyper-box could be occupied
by only one solution through comparing with an
identification array of the archive, which guarantees the
diversity of the archive. The total number of pareto-
optimal solutions, i.e. the final size of suitable solutions,
can be controlled approximately by adjusting the εj value
(see refs [58] and [57] for more details).
Two scoring functions, the energy score and the contact
score of DOCK, were considered in practical virtual screen-
ing. Traditional optimization methods, such as the simplex
method used in DOCK, are unsuitable for multi-objective
optimization. For the impartiality of the comparison,
GAsDock, which also uses a stochastic algorithm based on
modified multi-population genetic algorithm[25], was
adopted for single scoring function optimization. The
contact score also performed reasonably well in this study,
whichcoincideswithotherstudies[31,59,60].Energyscore
andcontact score wereconsideredasthe twoobjectivesinε-
MOEA (Figure 1a), that is, a set of pareto-optimal solutions,
which were satisfied simultaneously with energy score and
shape complementarity, were obtained consequently (see
additional file 1: Docking example and proof of method).
The multi-objective optimization model of ε-MOEA con-
sists of a set of n parameters (design variables), a set of l
Figure 1
The flowchart of Multi-Objective Scoring Function Optimization Methodology.( a )ε-MOEA method for virtual
screening. (b) EFMOGA method for virtual screening.
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(page number not for citation purposes)objective functions, and a set of m constraints. Objective
functions and constraints are functions of the decision
variables. It can be formulated mathematically as follows:
min yf x x x x
gx x x
== () ( 1 ff f
st g g
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and x is the design vector x ={ Tx, Ty, Tz, Rx, Ry, Rz, Tb1,. . .
Tbn}
T,i nw h i c h( Tx, Ty, Tz)a n d( Rx, Ry, Rz)a r e
respectively the state variables of translation and rotation
of the entire ligand for the orientation search; and Tb1,. . . ,
Tbn are the torsion angles of the n rotatable bonds of the
ligand for the conformation search. Accordingly, the
constraints for the design variables (g(x)s)c a nb e
represented as
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y is the objective vector, which consists of energy score
f1(x) and contact score f2(x), respectively. Of course,
more scoring function can be used in this method, but
no more scoring function source can be accessed. Here
t h es c o r i n gf u n c t i o n so fD O C Kw e r ej u s tu s e dt od e a l
with this problem. X is denoted as the decision space,
and Y is called the objective space.
Selection of the optimum and ranking in ε-MOEA case
As stated above, a set of pareto-optimal solutions
were obtained by using ε-MOEA, which simultaneously
s a t i s f i e de n e r g ys c o r ea n ds h a p ec o m p l e m e n t a r i t y .
There are two ways to select an optimal solution
from the set of pareto-optimal solutions:M O E A _ N r g
or 'energy score ≻ contact score' with the lowest energy
conformation and acceptable shape complementarity; and
MOEA_Cnt or 'contact score ≻ energy score' with the best
shape complementarity conformation and acceptable
energy score. The results of MOEA_Nrg and MOEA_Cnt
were all compared with their corresponding individual
scoring functions, respectively (see Results)
EFMOGA
Briefly, a new fast flexible docking program (GAsDock)
[25, 61] was developed using a multi-population genetic
algorithm based on information entropy[62, 63]. In
comparison with other docking methods, information
entropy was employed in the genetic algorithm of
G A s D o c ka n dt h es i z eo ft h en a r r o w e ds p a c ew a su s e d
as the convergence criterion, ensuring that GAsDock can
converge rapidly and steadily. A detailed description of
the algorithm has been presented elsewhere[25].
In this paper, EFMOGA-based GAsDock was applied to
solve the above-mentioned multiple scoring function
problem. According to GAsDock, the optimization
problem (Eq.2) can be transformed into the following
evaluation function model
min h F
s
sfx
st g g g
ii
i
l
m
( ) ln exp( ( ))
. . ( ) ( ( ), ( ),...,
=
=
= ∑
1
1
12
l
gx x x ( () )
( , ,..., )
( , ,..., )
x
xX
yY
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12
where x x x
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where li is the weight of each objective. (li ≥ 0a n d
li
i
l
il ==
= ∑ 11 2
1
( , ,..., )). By varying the weights, a set of
noninferior solutions was generated. s is a positive real
variable, when s Æ ∞, the minimization problem
converges to the maximal fi(x), and the minimum is
the pareto solution (see additional file 1: Docking
example and proof of method)
A knowledge-based method was adopted to obtain
appropriate weights for virtual screening, i.e. a set of
conformations of the ligand, which are obtained through
adjusting the weights, is compared with the ligand in the
X-ray crystal structure, and the weights with minimum
RMSD are selected. These are considered to best reflect the
test values for the current target system, i.e. the most
reasonable solution. During this process, useful informa-
tioncanbeacquiredsimultaneouslysuchastheadaptability
of different scoring functions to the current system, that is,
which scoring function contributes more to the current
system, and which scoring function is more sensitive.
As a result, various weights are obtained for different test
systems in virtual screening (Figure 1b). For virtual
screening of a database, each system only adopts one set
of weights, which makes the comparison more equitable.
Different from ε-MOEA, EFMOGA yields one solution
corresponding to the weight in the pareto-optimal solu-
tions rather than a set of pareto-optimal solutions.
Certainly, compared with single objective optimization,
the solution obtained here may be worse than any single
objective solution, but more reasonable than any
extremum obtained by a single objective method
because it has considered multiple-objective functions.
During the preparation of this manuscript, Grosdidier
et al. have developed a new docking software, EADock,
based on a multi-objective optimization algorithm, and
the results indicate that EADock can accurately predict
BMC Bioinformatics 2009, 10:58 http://www.biomedcentral.com/1471-2105/10/58
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fitness functions[64].
Results
As mentioned above, our study is not aimed at calculating
absolute values for the free energy of binding and for the
affinity, but focuses on the ranking of acceptable conforma-
tions for the multiple solution space. Because of the
different preferences in the selection of pareto-optimal
solutions with ε-MOEA, the results of three different
approaches will be compared with individual scoring
functions, namely one with preferred energy score for ε-
MOEA (MOEA_Nrg), the other with preferred contact score
for ε-MOEA (MOEA_Cnt), and the third for EFMOGA.
Docking to the buried lipophilic site of COX-2
The COX-2 ligand binding site is a completely buried,
narrow, confined and predominately lipophilic cavity
(Figure 2a)[50, 65], which does not accommodate many
orientations or conformations of a ligand. Consequently,
shape complementarity was expected to be very important.
MOEA_Nrg efficiently eliminates conformations that could
not satisfy shape complementarity although they displayed
good energyscores. The maximum enrichmentwas2.8-fold
over random, which was reached at the top 8.8% of the
database when using a single energy score for optimization,
but the maximum enrichment was 3.9-fold over random,
and moved up to the top 2.6% of the database when using
MOEA_Nrg (Figure 3a). MOEA_Cnt also got a good
enrichment (EF = 3.4485) at the top 0.4% of the database,
butitwasworsethansinglecontactscorewithEF=6.9atthe
top 0.2%. There are several possible explanations; first, the
conformation with highest contact score cannot satisfy
energy score, that is, the conformation that has the best
contact score but a bad energy score not among the pareto-
optimal solutions will be eliminated; second, the scoring
functionisimprecisewhichisthecommondisadvantagefor
all the scoring functions. Interestingly, although contact
score maintained higher enrichment among the top 2% of
the database, the same enrichment as that of MOEA_Nrg
was obtained at the top 2% of the database, and from this
point, the enrichment peak of MOEA_Nrg became broader.
EFMOGA has a similar curve as that of MOEA_Cnt, and a
maximum of 6.1-fold over random was reached at the top
0.2% of the database.
In the real application, only a small number (< 2%) was
our interesting section within a large source library.
MOEA_Nrg exhibited a good performance in this case
(Figure 3b, Figure 4a), MOEA_Nrg maintained the best
performance among all the methods, and retrieved 7.8% of
Figure 2
The characteristics of three binding sites. COX-2 with
Sc-558.(b)ERwith4-Hydroxytamoxifen.(c)ThrombinwithMqpa.
Figure 3
Enrichment of 695 active compounds of COX-2 in docking screens. (a) The enrichment factor of docking the database
by MOFOM and individual scoring function. (b) The percentage of the active compounds found by MOFOM and individual
scoring function. The plot shows the results using five optimization methods: Energy score (black), Contact score (red),
EFMOGA (cyan), MOEA_Nrg (green), and MOEA_Cnt (blue), respectively.
BMC Bioinformatics 2009, 10:58 http://www.biomedcentral.com/1471-2105/10/58
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total library (Figure 3b, Figure 4a). EFMOGA outperformed
single energy score among the top 5% of the library, and
retrieved 6% of active compounds among the top 2% of
the database, although it performed worse than single
contact score. Whereas, MOEA_Cnt represents a relatively
weak ability than single contact score before the top 5% of
the database, but greatly increases thereafter.
Docking to the relatively large hydrophobic
site of Estrogen Receptor
As an example of a well-understood target with
therapeutic relevance whose crystallographic structural
data were publicly available, estrogen receptor was
c h o s e n .L i k eC O X - 2 ,t h eb i n d i n gs i t eo fe s t r o g e nr e c e p t o r
is a relatively larger, fully-enclosed lipophilic cavity
(Figure 2b), which is little opened to solvent, there are
acceptor groups at either end that can form hydrogen
bonds with ligands, but it is predominantly hydrophobic
on the whole[49, 65].
For this case, EFMOGA performed well among the top
5% of the database, especially before the top 2%, and
reached the maximum enrichment (EF = 14.4) at the top
0.2% of the database (Figure 5a). Single energy score
exhibited the poorest performance in all methods, the
Figure 4
Histogram of active compounds found with five MOFSOM and single scoring function for assaying between
the 2%, 5%, 10% and 15% of the ranked database against each system. (a) COX-2 system, (b) Estrogen receptor
system, (c) Thrombin system with five optimization methods: Energy score (red), Contact score (cyan), EFMOGA (blue),
MOEA_Nrg (green), and MOEA_Cnt (pink), respectively.
Figure 5
Enrichment of 105 active compounds of ER in docking screens. (a) The enrichment factor of docking the database
by MOFOM and individual scoring function. (b) The percentage of active compounds found by MOFOM and individual
scoring function. The plot shows the results using five optimization methods: Energy score (black), Contact score (red),
EFMOGA (cyan), MOEA_Nrg (green), and MOEA_Cnt (blue), respectively.
BMC Bioinformatics 2009, 10:58 http://www.biomedcentral.com/1471-2105/10/58
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at the top 0.2% of the database, although MOEA_Nrg
reached the same enrichment, MOEA_Nrg outperformed
single energy score after that. Different from COX-2,
MOEA_Cnt indicated a very good performance than
single contact score for this case, it is more reasonable
that we preferred contact score from pareto-optimal
solutions to select the better shape satisfaction with
slight difference in energy score. Using single contact
score, the maximum enrichment (EF = 7.2) was reached
at the top 0.4% of the database, but the maximum
enrichment rose to 9.6, and moved up to the top 0.2% of
the database when using MOEA_Cnt.
Similar to COX-2, approximately 5.7% of active com-
pounds were retrieved using MOEA_Nrg at the top 2% of
the database (Figure 5b, Figure 4b), which was about
twofold over that of single energy score. Relative to
single contact score, MOEA_Cnt retrieved 9.5% of the
active compounds at the top 2% of the database, but
only less than 5% of the active compounds were
retrieved using single contact score. It is encouraging
that EFMOGA represents better performance than energy
score and contact score at the top 2% of the database,
with 8% of active compounds retrieved.
Docking to the intermediate polarity site of Thrombin
In contrast to COX-2 and estrogen receptor, the binding
site of thrombin is an intermediate polarity site[65], with
a large hydrophobic pocket (a smaller proximal and a
larger distal pocket) which is a more exposed binding
site to solvent[48], in addition, there is a S1 specificity
pocket, which is a narrow and restricted pocket
comprising the carboxylate group of Asp189 at the
bottom, most thrombin inhibitors form hydrogen bonds
with Asp189 and also to Gly216 (Figure 2c). Due to
many polar groups in the binding site, it is difficult to
distinguish active compounds for DOCK energy score
which is most reliable for the apolar active site, unlike
those scoring functions with extra consideration of
hydrogen bonding interactions such as PMF or FlexX
score[18, 34, 65-67].
As expected, although the maximum enrichment was 2
at the top 6.4% of the database for MOEA_Nrg, and the
maximum enrichment was 2.2 at the top 5.5% of the
d a t a b a s ew h e nu s i n gs i n g l ee n e r g ys c o r e ,t h e r ei sas l i g h t
increase in quantity using MOEA_Nrg against single
energy score at the top 2% of the database (Figure 6a).
MOEA_Nrg slightly underperformed than single energy
score after the top 2% of the database (Figure 6b). Like
ER case, MOEA_Cnt performed the best in all the
methods, the maximum enrichment (EF = 8.3) was
reached at the top 0.2% of the database, approximately
twofold over contact score, with a maximum value of 4.9
at the top 0.2% of the database (Figure 6a), at the same
time, 9.4% of the active compounds were retrieved with
MOEA_Cnt at the top 2% of the database (Figure 4c).
Same as other two systems, EFMOGA continues a good
performance at the top 2% of the database, with a 3.0
enrichment reached at the top 0.6% of the database, and
retrieved approximately 5% of the active compounds at
Figure 6
Enrichment of 646 active compounds of thrombin in docking screens. (a) The enrichment factor of docking the
database by MOFOM and individual scoring function. (b) The percentage of active compounds found by MOFOM and
individual scoring function. The plot shows the results using five optimization methods: Energy score (black), Contact score
(red), EFMOGA (cyan), MOEA_Nrg (green), and MOEA_Cnt (blue), respectively.
BMC Bioinformatics 2009, 10:58 http://www.biomedcentral.com/1471-2105/10/58
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contact score, but better than that of energy score,
EFMOGA and MOEA_Nrg performed not so well
compared with single score function after the top 5%
of the database.
Discussion
Performance of MOSFOM and Characteristics of binding
site and preferential selection of scoring function
Simple as it is, contact score performed unexpectedly
well for all the three systems in our study. Especially at
the top 5%, contact score performed better than energy
score, possibly arising from molecular diversity of the
randomly selected ACD database, which distributes well
not only in heavy atoms but also molecular torsions.
Contact score can rapidly seek out those whose geometry
shape can satisfy the binding site (containing shape and
volume), which is especially obvious to those with
completely buried and narrow cavity. However, energy
score presented a weak ability to distinguish the active
compounds from the decoys with shape satisfaction.
It is encouraging that compared with individual score,
every method of MOSFOM presented an increase not
only in enrichment but also hit rates of the active
compounds retrieved in some ways. EFMOGA with
different weights in different systems obtained better
r e s u l t st h a ns i n g l es c o r ea tt h et o p5 %( e s p e c i a l l ya tt h e
top 2%) of the database for all three cases in this study
(see Results), but gradually faded afterwards. It can be
easily understood that those active compounds with
high affinity and good shape complementarity were first
retrieved, and then those emphasizing particularly on
the larger weight in different test system were obtained,
consecutively. Therefore, if not knowing which scoring
function will work better for the test system in advance,
more enrichment can be obtained with EFMOGA in the
most interesting section (generally 2%) of the database.
It should be noted that EFMOGA, with different weights
for different test systems through experimental protein-
ligand complex, is more reasonable and different from
the simple linear combination (LC)[68] of several
scoring functions or ScreenScore through a combination
of scoring terms[69]. EFMOGA seems more pertinent
and advantageous, and will be a tendency for scoring
and ranking to consider different scoring functions
focusing on diverse aspects for different systems.
Different from EFMOGA, ε-MOEA selected the prefer-
ential solution from a pareto-optimal solutions family
(parts of the pareto frontier) through multi-objective
optimization using multiple scoring functions (see
Methods). With different preferences, MOEA_Nrg and
MOEA_Cnt all outperformed their corresponding
individual scoring function, i.e., MOEA_Nrg correspond-
ing to energy score and MOEA_Cnt corresponding to
contact score. A higher enrichment and hit rates of the
active compounds were obtained using MOEA_Nrg than
using individual energy score in COX-2 and ER system,
but there is an inverse phenomenon for thrombin case.
There are several strong hydrogen bond interactions
between the ligand and the residues in S1 pocket for
thrombin system. If we select the one with lowest energy
score from the docked conformations with acceptable
shape complementarity, more compounds will have
good shape complementarity conformations but are
only slightly different in energy score, since the energy
score does not pay more additional attention to the H-
bond interaction. In this case, it will be more difficult to
distinguish the active compounds. On the contrary,
MOEA_Cnt performed well for the thrombin and ER
case, where an open cavity exists, accommodating
enough orientations or conformations of a ligand,
therefore, it seems more reasonable that MOEA_Cnt
selected the best shape complementarity conformation
with differences in energy score. So, if one does know
which scoring function will work better for the test
system in advance, more enrichment and better perfor-
mance can be obtained using ε-MOEA through relative
preference.
Limitations of MOSFOM, further improvements and
prospect in bioinformatics and drug design
More scoring functions, which pay special attention to
hydrogen bonding interaction, or chemical complemen-
tarity, solvent effect, should be involved in multi-
objective optimization, however, there are only energy
score and contact score available for us. Although
MOSFOM performed better than individual score, there
will be more choices for MOFSOM in specific test system
if more interactions were considered. We can determine
different weights of scoring functions because EFMOGA
can be determined to deal with different cases and
maybe prefer others (e.g. chemical complementarity or
hydrogen bonds) for ε-MOEA if we know which scoring
function will work well for specific test system in
advance. Therefore, to develop scoring functions with
focus on hydrogen bond, icon or solvent effect and to
utilize multi-objective optimization to acquire more
reasonable conformations is one of our future research
interest.
At the same time, ignorance of the impact of protein
flexibility is another limitation for MOSFOM, small
changes of the receptor flexibility result in larger variety
of binding affinities[70], and docking to a single receptor
conformation will significantly reduce the chance of
finding the correct pose. Considering protein flexibility
BMC Bioinformatics 2009, 10:58 http://www.biomedcentral.com/1471-2105/10/58
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is crucial for medicinal chemists to find out the structure-
activity relationship. We will fulfil this work in the
future. Also, computational time of multi-objective
optimization is another issue to be solved. There are
numerous multi-objective optimization methods, how-
ever, they are not suitable for large-scale virtual screening
because of the huge time consumption, in this paper,
ε-MOEA, which is a steady-state MOEA based on the
ε-dominance concept, fulfilled virtual screening quickly
within about one minute for one molecule, and
EFMOGA, which is a multi-population MOGA based
on information entropy, accomplished one docking
within 40 seconds using one CPU on SGI origin3800
hardware. However, more improvements are needed to
find a set of well-distributed solutions close to the true
pareto frontier pragmatically and efficiently.
As stated above, multi-objective optimization approach has
been adopted in the library design program MoSELECT[39,
71-73] and quantitative structure activity relationships
program MoQSAR[74]. We believe that MOEA or MOGA
also can be applied to biological sequence alignment,
protein fold recognition, conformational generation and
ADME/TOX (absorption, distribution, metabolism, excre-
tion and toxicity) with more and more factors taken into
account in bioinformatics and drug design.
Conclusion
Development of a fast and accurate scoring function in
virtual screening is still a hot and pending issue in current
research, different scoring functions focus on different
aspects of ligand binding, and no single scoring can satisfy
all the systems well, therefore, consensus score was put
forward.[35, 36] With several other scoring functions,
consensus score re-assessed those conformations optimized
using a primary scoring function, but it is not really robust
from the viewpoint of optimization. All of these give rise to
another heuristic thinking for us, is it possible and more
rational to find a most reasonable conformation in the
processofoptimizationusingtwoormorescoringfunctions
in virtual screening? Since present scoring functions can not
satisfy all the cases, multi-objective optimization method
can be a good compromise.
In this study, we present two kinds of multi-objective
optimizationmethod,calledMOSFOM,invirtualscreening
which simultaneously considers energy score and contact
score. A set of pareto-optimal solutions were obtained which
can simultaneously satisfy energy and shape complemen-
tarity using ε-MOEA method, then through two different
preferences, the binding conformations of pareto-optimal
solutions with lowest energy scoring or best shape
complementarity were ranked among all selected
conformations. However, EFMOGA acquires different
weights of each scoring function for different systems
based on experimental X-ray complex structure, that is, for
different system, EFMOGA regards the varying weightas the
degreeofcontributionofindividualscoringfunction,which
generally focuses on one aspect for a special type of binding
sites, this means the scoring function with bigger weight is
more suitable for the binding site. We used 10000 random
compounds as the decoys, active compounds selected from
MDDR database were randomly merged into the decoys,
respectively. To ensure justness of comparison, GAsDock,
based on an improved genetic algorithm, was used as a
benchmark for single-objective optimization. Results show
that MOSFOM can enhance the enrichment and greatly
increase the hit rates compared with individual score (see
Results). For three different kinds of binding sites,
MOSFOM represents excellent ability of distinction of
active compounds withenergy andshape complementarity.
EFMOGA specially performed well at the top 2% of the
database, MOEA_Nrg and MOEA_Cnt performed better
than individual scoring function if a proper type of binding
site was selected.
Multi-objective optimization method was successfully
applied in virtual screening with two different scoring
functions, which can gainreasonable binding pose, andcan
be furthermore rankedwith those potentially compromised
conformations of each compound which abandon those
conformations that can not satisfy overall objective func-
tions. By analyzing the characteristics of binding site in
advance, the most effective multi-objective optimization
method is adopted, which is meaningful for all current
scoring functions since they can not suit all cases. More
specific scoring functions and protein flexibility will be
taken into account in our future work.
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